Riskpilot← Back to searchSign inGet full accessAnamnesis Oy
OYDissolvedY-tunnus 3146501-1D A 39Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2024
EUR 510K
EBITDA margin
137.9%
Equity ratio
68.5%
Financial strength
Net profit 2024
EUR 175K
1 employees
| Revenue | EUR 510K | — |
| EBITDA | EUR 704K | — |
| Net profit | EUR 175K | — |
| Total assets | EUR 1,1M | — |
| Equity | EUR 749K | — |
| Employees | 1 | — |
Legal name
Anamnesis Oy
Y-tunnus number
3146501-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
9. heinäkuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Lääkäripalvelut, terveyspalvelut sekä kaikki muu liiketoiminta
Address
D A 39
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 277 | 430 | 0 | 510 |
| Staff expenses | −34 | −50 | −66 | −1 769 |
| EBITDA | 178 | 263 | 0 | 704 |
| Depreciation & amort. | −0 | −1 | −4 | −10 |
| EBIT | 178 | 262 | 0 | 704 |
| Net financials | −0 | −2 | 0 | 1 166 |
| Profit before tax | 178 | 259 | 0 | 422 |
| Tax | 39 | 53 | −0 | 43 |
| Net profit | 139 | 207 | 0 | 175 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 177 | 520 | 0 | 1 094 |
| Equity | 139 | 341 | 0 | 749 |
| Long-term debt | — | 107 | 0 | 275 |
| Short-term debt | 38 | 72 | 0 | 70 |
| Total debt | 38 | 179 | 0 | 345 |
EBITDA margin
137.9%
This company
15.8%
Market median
+773% vs market
20212024
Equity ratio
68.5%
This company
38.2%
Market median
+79% vs market
20212024
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20212024
Net profit margin
34.2%
This company
8.1%
Market median
+322% vs market
20212024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20212024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AU Chief Executive Officer | Chief Executive Officer | 2020 |
TR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
| Former (1) | ||
AM | Audit | 2022 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Anamnesis Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ari-Pekka Markus Poikonen | Audit | 0 companies |
| Antti Urpo Kuivaranta | Chief Executive Officer | 0 companies |
| Tiia Riikka Susanna Kuivaranta | Deputy Chief Executive Officer | 0 companies |